MyWay Digital Health

Name

MyWay Digital Health

Legal name

MyWay Digital Health Ltd

Website

https://mywaydigitalhealth.co.uk

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Digital Health Software

NAICS

Software Publishers (5132), Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

akta.pro secondary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Digital health platforms
• Chronic disease management
• Diabetes self-management software
• Remote patient monitoring
• Clinical decision support systems

Headquarters

HQ city

Dundee

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. NHS and Healthcare Licensing: Licensing model where NHS trusts, private healthcare companies and insurers pay a per-patient-per-year fee for access to the MyWay Diabetes platform and associated tools. Sold predominantly to NHS trusts and commissioning bodies through NHS frameworks.
2. International Licensing: International commercial agreements with healthcare providers in the Middle East and Asia, including agreements with Dallah Healthcare (Saudi Arabia) and regional partners in Malaysia and UAE.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels11 records

Core offering

MyWay Digital Health develops and licenses AI-enabled digital health platforms for the self-management and clinical management of diabetes and other long-term conditions. The four product lines — MyWay Diabetes (patient app), MyWay Clinical (clinician platform), MyWay Education (QISMET-accredited eLearning), and MyWay Health (overarching chronic care platform) — are sold to NHS trusts, Integrated Care Systems, private healthcare companies, insurers and international healthcare providers on a per-patient-per-year licensing model.

Product overview

MyWay Digital Health offers a platform-plus-modules architecture consisting of four main products: MyWay Diabetes (flagship patient-facing self-management platform), MyWay Clinical (clinician-facing records and analytics platform), MyWay Education (structured eLearning and education resources), and MyWay Health (overarching chronic condition management platform). These products work together to provide an integrated digital health ecosystem where patients can access their health records, receive personalised advice, complete education courses, and share data with healthcare providers, while clinicians can manage patient data, receive alerts, generate performance reports, and use risk prediction tools. The platform connects to NHS systems (EMIS, Vision) and supports NHS Login authentication, serving patients across multiple NHS regions in England including Greater Manchester, Somerset, North East London, and North Central London, as well as international markets in the Middle East.

Differentiator

Problem solved

Functional benefit

Brands

• MyWay Diabetes: Flagship diabetes self-management platform offering personalized guidance and secure access to medical data for individuals with diabetes. A top-rated, market-leading product used across NHS regions and internationally.
• MyWay Clinical
• MyWay Health
• MyWay Education

Products and services

• MyWay Health Self-management and education support platform with a patient data app that connects to healthcare providers and remote monitoring tools, covering diabetes, hypertension, cardiovascular disease and obesity. Sold to NHS trusts, private healthcare companies and insurers.
• MyWay Diabetes Market-leading patient-facing diabetes self-management platform offering personalised guidance, secure access to medical records, education resources and remote monitoring. Highest-ever ORCHA-rated diabetes app (92%). Free for patients; commissioned by NHS trusts, private healthcare companies and insurers.
• MyWay Clinical Platform for healthcare professionals to manage diabetes records and analytics, supporting remote patient care with decision support, alerting, performance reporting and AI-powered risk prediction. Sold to NHS trusts and international healthcare providers.
• MyWay Education Comprehensive diabetes education platform with 200+ peer-reviewed resources and QISMET-accredited structured eLearning courses, with personalised regional customisation linking to local services. Covers type 1, type 2, gestational diabetes, prevention, CGM technologies and insulin pumps.

Quantifiable outcome

• 5:1 return on investment through reduced long-term complications and patient care costs
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability4 records

Feature7 records

Partnerships

Twelve partnerships are on record, tiered minor, core and supporting.

• Microsoft Executive (unnamed)minorOthers · 1 September 2025A Microsoft executive joined MyWay Digital Health as it raised £3 million from Foresight Group, bringing enterprise technology and leadership experience to support the company's growth plans.
• Lean Business ServicescoreStrategic or Co-development Partner · 1 April 2024MyWay Digital Health signed an agreement with Lean Business Services at the LEAP conference near Riyadh, Saudi Arabia, to support improvements in population health and diabetes chronic disease management. The agreement represents a long-term collaboration for digital health deployment in Saudi Arabia.
• Dexcom UK & IrelandsupportingGTM or Marketing Partner · 1 February 2024Dexcom UK & Ireland became a Gold Sponsor of MyWay Digital Health's type 1 diabetes open online courses in February 2024. Dexcom enhances marketing and awareness for these courses by leveraging their network including the 'Dexcom Warrior' community, while offering insights into how their rtCGM devices assist individuals managing type 1 diabetes.
• Dallah HealthcarecoreStrategic or Co-development Partner · 4 December 2023Sukkary and MyWay Digital Health entered into an agreement with Dallah Healthcare in Saudi Arabia to launch both MyWay Diabetes and MyWay Clinical platforms. The goal is to improve self-management of people with diabetes and provide insights for healthcare professionals managing their care. Platforms made available to thousands of people with diabetes and HCPs in clinics initially in 2024, with expansion plans.
• SukkarycoreChannel Partner/ Reseller/ Distributor · 3 March 2023MyWay Digital Health partnered with local Saudi business Sukkary to launch a pilot of the MyWay platform with the Ministry of Health, Hail Cluster in Saudi Arabia. Sukkary serves as the local partner for deployment, with a 6-month pilot targeting up to 1,000 users, with both patient-facing MyWay Diabetes and MyWay Clinical platforms being deployed.
• University of Edinburgh (AI Accelerator)supportingStrategic or Co-development Partner · 1 February 2021Selected out of 86 applicants worldwide for the AI Accelerator programme based at the University of Edinburgh's Bayes Centre, in partnership with Scale Space. 15 pioneering start-ups were selected from which 6 were health tech start-ups. The programme is designed to accelerate the best AI start-ups to scale globally.
• NHS EnglandcoreStrategic or Co-development PartnerNHS England partnership including hosting the national mytype1diabetes.nhs.uk platform. Partnership on NHS Innovation Accelerator Programme and NHS Health Systems Support Framework (HSSF) accreditation.
• Diabetes and Ramadan International AlliancesupportingStrategic or Co-development PartnerPartnership with the Diabetes and Ramadan International Alliance to deliver free online courses helping Muslim people with diabetes fast safely during Ramadan. Courses delivered in English, Arabic, and Malay.
• Pulse Active Stations Network (India)supportingStrategic or Co-development PartnerCollaboration with Pulse Active Stations Network in India for digital health initiatives.
• NHS DigitalcoreTechnology or IntegrationNHS Login integration allowing secure authentication for patients. NHS Digital is the controller for personal information used to create NHS login accounts and verify identity.
• University of DundeecoreStrategic or Co-development PartnerMyWay Digital Health spun out of the University of Dundee. Co-founders Dr Debbie Wake and Dr Scott Cunningham designed and developed diabetes management solutions at the university for over 20 years, including leading development of national diabetes platforms in Scotland.
• NHS Trusts (Somerset, Greater Manchester, North East London, North Central London)coreStrategic or Co-development PartnerRegional NHS trusts commission the MyWay Diabetes platform for deployment across their populations. Somerset NHS Foundation Trusts, Greater Manchester, NHS North East London, and NHS North Central London are key NHS partners.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Oviva: European digital health company providing app-based coaching and remote monitoring for diabetes, obesity, and other chronic conditions, sold to NHS trusts and European payers. Highly comparable to MyWay's chronic-disease self-management + remote monitoring model and NHS commissioning GTM.
• mySugr (Roche): Diabetes self-management app acquired by Roche, offering patient logging, coaching, and CGM integration. Direct functional peer to MyWay Diabetes on patient-side diabetes self-management, but with substantially greater distribution through pharma and CGM partners.
• Glooko: Diabetes data management platform that aggregates data from 95+ devices (BGM, CGM, insulin pumps) and integrates with EHR systems for clinicians and patients. Directly comparable to MyWay Clinical's device integration and clinician analytics capabilities, with broader device compatibility.
• Liva Healthcare: European digital health platform offering lifestyle coaching and remote monitoring for type 2 diabetes, obesity, and cardiovascular disease, with NHS contracts and European payer deals. Closely comparable to MyWay on chronic-condition coaching, NHS commissioning, and platform-plus-coaching model.
• Diabetes Digital Media (DDM): UK-based digital health company providing diabetes education, self-management tools, and the Low Carb Program. Comparable UK-centric diabetes self-management and education platform competing for similar NHS and patient audiences, though more consumer/D2C and less clinician-platform focused.

Broad incumbents

• Omada Health: US-based digital therapeutics incumbent offering virtual care programs for diabetes prevention, diabetes, hypertension, and musculoskeletal conditions through employer and payer contracts. Comparable chronic-condition digital therapeutic model but at much larger scale and with US-centric employer GTM rather than NHS commissioning.
• Vida Health: US virtual chronic care provider combining app-based coaching, remote monitoring, and clinician visits for diabetes, hypertension, mental health, and weight management. Comparable multi-condition digital chronic care platform, but US-payer focused and broader in scope than MyWay's diabetes-first portfolio.
• Hinge Health: Large-scale digital musculoskeletal and chronic pain platform combining sensor-guided exercise therapy with coaching, sold to US employers and health plans. Comparable digital chronic-care therapeutics business model and employer/payer GTM, but focused on MSK rather than metabolic conditions.

Regional players

• Wellthy Therapeutics: India-based digital therapeutics company focused on diabetes, hypertension, and cardiovascular disease management, with partnerships across India and Southeast Asia. Comparable chronic-disease digital therapeutic model and a relevant regional peer as MyWay expands into the Indian and Malaysian markets.

Emerging players

• Dacadoo: Swiss digital health platform offering a health score engine combined with coaching and chronic-condition support, sold to insurers and corporate customers in Europe and Asia. Comparable digital health platform + chronic care + insurance/employer GTM, though narrower on condition-specific decision support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MyWayDigital
• Facebookfacebook.com/MyWayDigitalHealth
• LinkedInlinkedin.com/company/26998608
• Instagraminstagram.com/mywaydigitalhealth

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyWay Digital Health